A description of Iofina’s business can be accessed here
This section of the website contains information required to be disclosed by rule 26 of the AIM Rules for Companies. The Company does not intend documents posted or referred to in this section of the website to be used for any purpose beyond fulfilling its obligations under rule 26.
Any such documents may contain information which has become out of date, and accordingly no reliance should be placed on the information or opinions contained in any such document or on its completeness and no undertaking, representation, warranty or other assurance, express or implied, is made or given by or on behalf of the Company or any of its directors, officers, partners, employees, agents or advisers or any other person as to the accuracy or completeness of the information or opinions contained in any such document and no responsibility or liability is accepted by any of them for any such information or opinions. In addition, none of such documents constitutes or forms part of, any offer or invitation to sell, allot or issue or any solicitation of any offer to purchase or subscribe for any securities, nor shall it (or any part of it) or the fact of its publication form the basis of, or be relied upon in connection with, or act as any inducement to enter into, any contract or commitment for securities. The distribution of any such document in other jurisdictions may be restricted by law and therefore persons into whose possession any such document comes should inform themselves about and observe any restriction.
This page was last updated: 7 May 2026
The Board recognises the importance of good corporate governance and is committed to achieving high standards of governance commensurate with the size and stage of development of the Company and its group of companies. Iofina, as an AIM-quoted company, has chosen to apply the QCA Code. The principles set out in the QCA Code, as applied by the group, take in to account the stage of development, resources available and the size of the group. The QCA Code identifies 10 principles to be followed to deliver growth in long-term shareholder value by ensuring that the management framework is efficient, effective and dynamic, supported by good stakeholder communication to promote confidence and trust.
To see how we adhere to the principles set out in the QCA Code please click the ‘Our QCA Code’ link below.
The Board meets regularly to review, formulate and approve the Group’s strategy, budgets, corporate actions and oversee the Group’s progress towards its goals. The Board has established an Audit Committee and a Remuneration Committee, with each committee fulfilling specific functions and having formally delegated duties and responsibilities. These committees meet as needed throughout the year. The Board has elected not to constitute a dedicated nomination committee, instead retaining such decision making with the Board as a whole. This approach is considered appropriate to enable all Board members to take an active involvement in the consideration of Board candidates and to support the Chair in matters of nomination and succession.
The Audit Committee receives and reviews reports from the management and the external auditors of the Group relating to the annual and interim accounts and the accounting and internal control systems of the Group. It has unrestricted access to the Group’s external auditors. The Audit Committee is comprised of Lance J. Baller (who serves as the committee chair), Tim Hughes, J. Frank Mermoud, and Mary Fallin Christensen.
The Remuneration Committee sets and reviews the scale and structure of the Executive Directors’ and senior management’s remuneration and the terms of their service contracts with due regard to the interests of shareholders. The Remuneration Committee is comprised of Mary Fallin Christensen (who serves as the committee chair), Lance J. Baller, Tim Hughes, and J. Frank Mermoud.
The remuneration and terms and conditions of appointment of the Non-Executive Directors are set by the board. No director or member of the senior management is permitted to participate in discussions or decisions concerning his own remuneration.
Each committee has terms of reference, copies of which can be seen below.
Terms of Reference of the Audit Committee
Terms of Reference of the Remuneration Committee
The Company has established a share dealing code for dealings in its Ordinary Shares by Directors and employees which is appropriate for an AIM-quoted company.
Additional Notes:
Directors – Whilst the QCA Code recommends that shareholders be given the opportunity to vote annually on the (re-)election of all directors to the Board, the Board does not believe this to be in the best interests of the Company and its shareholders. The reasons are principally twofold. First, all Directors are subject to re-election by shareholders at the first annual general meeting after their appointment to the Board and must seek re-election at least once every three years. Shareholders therefore have an early opportunity to consider each director’s appointment. Secondly, the Board believes that directors with extended terms are better positioned to focus on the Company’s long-term strategy rather than being pressured by short-term shareholder activism. The Board further believes that directors who do not have to worry about re-election every year are less susceptible to pressure from, or the need to appease, short-term oriented activist investors, allowing them to make decisions based on the Company’s long-term interests rather than what may be popular, short-term demands, which the Board believes to be in the best interests of the Company and its shareholders and other stakeholders.
Remuneration Report – Whilst the QCA Code recommends that the annual remuneration report should be put to any advisory shareholder vote, the Company does not believe the increased administrative costs of seeking a separate vote on a matter which already forms part of the annual voting process to be in its best interests or those of its shareholders, particularly as the remuneration report forms part of the group’s annual report and accounts. Further, the Board believes that the Company already adopts a high standard of compliance in corporate governance matters and therefore considers a separate vote, which is only required to be an advisory one pursuant to the QCA Code, to be unnecessary to prove good governance.
A description of Iofina’s business can be accessed here
The names and brief biographical details of Iofina’s directors can be accessed here
Iofina plc is a company incorporated in England and Wales under the Companies Act 1985 with company no. 05393357. The Company’s shares are admitted to trading on AIM. As a result, Iofina plc is subject to the UK’s City Code on Takeovers and Mergers.
The address of the registered office is:
48 Chancery Lane
London WC2A 1JF
(c/o Keystone Law; Attn: Simon Holden)
The nature of the group’s operations and its principal activity is exploration, development and production of iodine and halogen-based specialty chemicals principally in the United States of America.
A copy of the Company’s articles of association can be accessed here
As at 31 March 2026, Iofina had in issue 191,858,408 ordinary shares of 1 pence each in the Company (“Ordinary Shares”). No shares are held in treasury. The figure of 191,858,408 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA’s Disclosure Guidance and Transparency Rules. In so far as the Company is aware, the percentage of Ordinary Shares not in public hands as at 31 March 2026 was 35.37%
The Company is aware of the following significant shareholders holding 3% or more of the issued share capital of the Company as at 31 March 2026.
| Shareholder | Percentage | |||
|---|---|---|---|---|
| Richard Sneller | 24.0%* | |||
| Interactive Investor (EO) | 12.84% | |||
| Mr. & Mrs. David Newlands | 11.11%* | |||
| Hargreaves Lansdown, stockbrokers (EO) | 10.36% | |||
| Above Tigh, llc | 4.42% | |||
| Barclays Smart Investor (EO) | 3.74% | |||
| AJ Bell, stockbrokers (EO) | 3.69% | |||
| Directors | 3.03% | |||
*Based on TR1 notifications received on 30 April 2026
There are no restrictions on the transfer of Iofina’s shares.
The securities of Iofina are traded on the AIM market operated by the London Stock Exchange plc.
Its shares have not been admitted, nor have any applications been made, for any of its shares to be admitted or traded on any other exchanges or trading platform.
All published annual reports and interim reports can be accessed here
A copy of the Company’s last 12 months of press releases can be accessed here
A copy of the Company’s admission document dated 2 May 2008, can be accessed here
A list of the Company’s advisors can be accessed here
